Oncology trial starts hit record levels as COVID disruptions ease: report

Oncology trial starts reached record levels in 2021—particularly in rare indications—as disruptions in cancer care brought on by the COVID-19 pandemic began to ease, according to the IQVIA Institute for Human Data Science.

The return to pace after a disruptive two years, when patients stayed home and missed crucial checkups, is certainly good news. But the IQVIA Institute’s new report did show that oncologists reported more new patients presenting with cancer that had spread due to delays in diagnosis and screenings.